Switch to:
More From Other Websites
Report Pursuant to Section 28a of the Danish Securities Trading Act Dec 15 2014
Grant of Restricted Stock Units to Board Members and Management and Grant of Warrants to Management... Dec 15 2014
GENCOR INDUSTRIES INC Financials Dec 13 2014
Genmab to Receive $3 Million Milestone Payment in DuoBody Platform Collaboration with Janssen Dec 12 2014
10-K for Gencor Industries, Inc. Dec 11 2014
GENCOR INDUSTRIES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Dec 09 2014
GENCOR INDUSTRIES INC Files SEC form 10-K, Annual Report Dec 09 2014
Gencor Releases Fiscal Year and Fourth Quarter 2014 Results Dec 09 2014
Genmab Announces Phase II Study of Daratumumab in Non-Hodgkin's Lymphomas Dec 04 2014
Genmab to Webcast Post-ASH Investor Seminar Dec 03 2014
Genmab's Total Number of Voting Rights and Total Share Capital Nov 28 2014
Genmab Announces Phase II Study of Daratumumab in Smoldering Multiple Myeloma Nov 24 2014
Genmab to Present at the Jefferies 2014 Global Healthcare Conference Nov 14 2014
Report Pursuant to Section 28a of the Danish Securities Trading Act Nov 12 2014
Capital Increase in Genmab as a Result of Employee Warrant Exercise Nov 12 2014
Genmab's Financial Calendar for 2015 Nov 10 2014
Genmab Announces New Phase III Combination Study of Daratumumab in Frontline Multiple Myeloma Nov 10 2014
Genmab Announces Daratumumab and Ofatumumab Data to Be Presented at American Society of Hematology... Nov 06 2014
Genmab Announces Financial Results for the First Nine Months of 2014 Nov 05 2014
Genmab Announces Conditional Transfer of Ofatumumab Agreement Nov 03 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK